NEW YORK (GenomeWeb News) – French genome engineering company Cellectis said last week that the Paris Tribunal de Grande Instance has dismissed a lawsuit filed against it by Genoway in January.

The third chamber of the Tribunal de Grande Instance returned a verdict stating, among other things, that a contract between Cellectis and Genoway was terminated on December 30, 2008; that the under-license products detained by Genoway must be destroyed; and that an audit of Genoway's accounts is to be resumed in order for Genoway to pay sums owed to Cellectis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.